4D Molecular Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
4D Molecular Therapeutics, Inc.
CIK #0001650648
EDGAR Form CIK 2011 - 2025
10-K [0001650648]
10-Q [0001650648]
3 [0001650648]
4 [0001650648]
8-K [0001650648]
D [0001650648]
SC 13G [0001650648]
Form 13D/13G Filer Form 13D/13G Subject Filed
Goldman Sachs Group Inc 4D Molecular Therapeutics Inc [2024-11-06]
Vanguard Group Inc 4D Molecular Therapeutics Inc [2024-11-04]
RA Capital Management LP 4D Molecular Therapeutics Inc [2023-06-05]
Venrock Healthcare Capital Partners III LP 4D Molecular Therapeutics Inc [2023-05-15]
Janus Henderson Group PLC 4D Molecular Therapeutics Inc [2022-02-11]
BlackRock Inc 4D Molecular Therapeutics Inc [2022-02-04]
Deep Track Capital LP 4D Molecular Therapeutics Inc [2021-11-04]
Biotechnology Value Fund L P 4D Molecular Therapeutics Inc [2021-07-06]
Pfizer Inc 4D Molecular Therapeutics Inc [2021-02-16]
Schaffer David 4D Molecular Therapeutics Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2025
4D Molecular Therapeutics, Inc.
Gray Susannah
Milligan John F
Miller-Rich Nancy
Theuer Charles
Tomasello Shawn
Chacko Jacob
Kamal Fariborz
Mehra Uneek
Kim Robert Young
View All
Terms | Privacy | Guide
tony@aum13f.com